Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV

Conditions: Vasculitis Interventions: Drug: Avacopan Sponsors: Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials